Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., ... & Grivas, P. (2020). Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. The Lancet.

Michigan State University

- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
- Clinical impact of COVID-19 on patients with cancer

Cancer Discovery Papers Related to COVID-19 Patient Comorbidities 

Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., ... & Gartrell, B. A. (2020). Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer discovery.
DOI: 10.1158/2159-8290.CD-20-0516
https://cancerdiscovery.aacrjournals.org/content/early/2020/05/05/2159-8290.CD-20-0516.abstract

Case Fatality Rate of Cancer Patients with
COVID-19 in a New York Hospital System

- Participants were selected if they presented with any malignancy or were diagnosed with cancer before
- The participants had COVID-19 
- The study lasted for a month upon diagnosis of COVID-19
- The study aimed at determining the mortality rate in these patients
- 13% of the patients died
- Those from the Northeast and Midwest parts of US and those from Canada had lower mortality cases
- Cancer type, race, and whether or not the patient was obese did not have an impact on the mortality rate
- Mortality was high for patients with COVID-19 and cancer, and there was an association with age and other general risk factors
- Hydroxychloroquine and azithromycin (cancer drugs) were also given to patients, but their benefits or harms in relation to COVID-19 are unknown


Cancer patients and COVID-19

Clinical Impact of COVID-19 on Patients with Cancer

Cattrini, C., Bersanelli, M., Latocca, M. M., Conte, B., Vallome, G., & Boccardo, F. (2020). Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer. Cancers, 12(8), 2325.
https://www.mdpi.com/2072-6694/12/8/2325

Learn Before

Related